This award supports studies that move promising preclinical or clinical research findings closer to clinical application for tuberous sclerosis complex, including diagnosis, prognosis, or treatment. It allows multiple principal investigators with distinct application requirements, fostering collaborative translational research projects focused on TSC clinical outcomes.
Open to any type of entity without restrictions, subject to additional clarifications in eligibility text. Multiple principal investigators allowed with specific application requirements.
